Medacist Returns to ASHP with Industry First Product Announcement
CHESHIRE, CT – Medacist returns to ASHP with industry first product announcement.
Medacist Solutions Group is the lead innovator in drug diversion analytics as evidenced by being granted the only US patent for Drug Diversion. We are proud to say that, thousands of hospitals across the US have relied on our RxAuditor Analytics suite to ensure regulatory compliance, reduce liability and ensure patient safety.
Our core initiative is to deliver actionable information focused on the medication use process to drive better patient safety outcomes for the customers we serve. As Medacist approaches our
20th anniversary we continue to innovate.
Come visit us at the ASHP Midyear Clinical Meeting at Booth 2061 to witness an industry first product announcement!
Please click here to download the entire article.